Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.65 | 12.92 |
| PEG Ratio (TTM) | -0.04 | 2.07 |
| P/S Ratio (TTM) | 0.07 | 2.86 |
| P/B Ratio (TTM) | 0.02 | 2.42 |
| P/FCF Ratio (TTM) | -0.30 | 3.68 |
| Price to 5YR AVG Earnings Ratio | -0.01 | 15.18 |
| Price to 5YR AVG FCF Ratio | 0.03 | -9.27 |
Profitability (23%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.08% | 5.19% |
| ROE (TTM) | 2.62% | 21.73% |
| Net Profit Margin (TTM) | 8.68% | -136.29% |
| ROIC 5YR AVG | 1.60% | 30.79% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9,135.91% | 14.12% | 89.12% |
| Revenue | 11.34% | 521.59% | 430.85% |
| Net Income | -65.91% | 15.37% | 137.63% |
| Cash Flow | 5.67% | -327.59% | -181.72% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.86 | 1.92 |
| Quick Ratio (TTM) | 7.86 | 1.50 |
| D/E Ratio (TTM) | 0.01 | 0.41 |
| Interest Coverage (TTM) | -4.71 | 0.55 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 0.70 | 3.26 |
| LTL to 5YR AVG FCF | 0.01 | -4.08 |
| Shares Outstanding Growth 5YR AVG | 1,445.70% | 20.35% |